首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1508778

魚疫苗市場：依疫苗類型、適應症、給藥途徑及地區分類

Fish Vaccine Market, By Vaccine Type, By Indication, By Route of Administration, By Geography

出版日期: 2024年06月11日 | 出版商:

Coherent Market Insights | 英文 177 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球魚疫苗市場規模為3.751億美元，預計2031年將達到6.912億美元，2024年至2031年的複合年成長率為9.1%。

是<.

圖 1. 2024 年按地區分類的魚疫苗市場佔有率(%)

由於水產養殖業的興起和致命魚病患病率的增加，全球魚疫苗市場在過去幾年呈現穩定成長。魚類疫苗有助於保護魚類族群免受感染疾病的侵害，並避免養魚戶和貿易業者遭受重大經濟損失。疫苗有助於對水產養殖的食用和觀賞魚類進行疫苗接種。魚貝類消費量的增加以及對永續魚類養殖的需求不斷增加，可能會在不久的將來增加全球對魚類疫苗的需求。

市場動態：

由於全球魚貝類需求的增加，擴大採用水產養殖方法可能會推動魚類疫苗市場的成長。養殖鮭魚中各種病毒和細菌感染（例如弧菌病和上皮囊腫）的盛行率不斷增加，特別是在歐洲和北美，可能會促進魚類疫苗的銷售。然而，與魚疫苗研發相關的高成本以及對新魚疫苗推出的嚴格規定可能會阻礙市場成長。另一方面，採用新型佐劑技術來開發高效的耐熱魚疫苗可能會為該行業的製造商提供利潤豐厚的商機。

本研究的主要特點

本報告對全球魚疫苗市場進行了詳細分析，並提出了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它闡明了不同細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球魚疫苗市場的主要企業。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球魚疫苗市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過分析全球魚疫苗市場時所使用的各種策略矩陣來促進決策。

公司簡介
- Merck Animal Health（MSD Animal Health）
- Zoetis
- Elanco
- Virbac
- HIPRA
- Veterquimica SA
- Tecnovax
- Phibro Animal Health Corporation
- Ridgeway Biologicals Ltd.
- Nisseiken Co., Ltd.
- Aquatic Animal Health Ltd
- Ictyogroup
- Benchmark Holdings plc
- Vaxxinova
- Alpha Biotech Ltd.
- Vallee SA
- Ringpu Biology
- Nippon Zenyaku Kogyo Co., Ltd.
- Chengdu Tech-bank Biological Products
- Weiyuan Gene Tech

第10章分析師建議

升起和降落
綜合機會圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5184

Global fish vaccine market is estimated to be valued at USD 375.1 million in 2024 and is expected to reach USD 691.2 million by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.

Figure 1. Fish Vaccine Market Share (%), By Region, 2024

Global fish vaccine market has witnessed steady growth in the past few years, owing to rise in aquaculture industry and increasing prevalence of deadly fish diseases. Fish vaccines help prevent fish populations from infectious diseases, thus, avoiding heavy economic losses to fish farmers and traders. Vaccines aid immunization of fish species that are raised through aquaculture practices for both food and ornamental purposes. Growing consumption of seafood along with rising demand for sustainable fish farming can boost demand for fish vaccines globally in the near future.

Market Dynamics:

Increasing adoption of aquaculture practices due to rising global seafood demand can drive the fish vaccine market growth. Increasing prevalence of various viral and bacterial infections such as Vibriosis and Epitheliocystis disease particularly among salmon species farmed in Europe and North America can boost sales of fish vaccines. However, high costs associated with fish vaccine R&D and stringent regulations pertaining to launch of new fish vaccines can hamper the market growth. Meanwhile, introduction of novel adjuvant technologies for developing efficient thermostable fish vaccines can provide lucrative business opportunities for manufacturers in the industry.

Key Features of the Study:

This report provides in-depth analysis of the global fish vaccine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global fish vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Zoetis, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac, Hipra, Veterquimica S.A., Tecnovax, Anthropic, HIPRA
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global fish vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish vaccine market

Detailed Segmentation-

By Vaccine Type:
- Killed Vaccine
- Inactivated Vaccine
- Attenuated Vaccine
- Toxoid Vaccine
- Subunit Vaccine
- Conjugate Vaccine
- Recombinant Vector Vaccines
By Indication:
- Furunculosis
- Vibriosis
- Yersiniosis
- Enteric septicaemia
- Others
By Route of Administration:
- Injection
- Immersion
- Spray
- Oral
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Merck Animal Health (MSD Animal Health)
- Zoetis
- Elanco
- Virbac
- HIPRA
- Veterquimica S.A.
- Tecnovax
- Phibro Animal Health Corporation
- Ridgeway Biologicals Ltd.
- Nisseiken Co., Ltd.
- Aquatic Animal Health Ltd
- Ictyogroup
- Benchmark Holdings plc
- Vaxxinova
- Alpha Biotech Ltd.
- Vallee S.A.
- Ringpu Biology
- Nippon Zenyaku Kogyo Co., Ltd.
- Chengdu Tech-bank Biological Products
- Weiyuan Gene Tech

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Indication
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Fish Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Fish Vaccine Market, By Vaccine Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Killed Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Inactivated Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Attenuated Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Toxoid Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Subunit Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Conjugate Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Recombinant Vector Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Fish Vaccine Market, By Indication, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Furunculosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Vibriosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Yersiniosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Enteric septicaemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Fish Vaccine Market, By Route of Administration, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Immersion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Fish Vaccine Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Merck Animal Health (MSD Animal Health)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zoetis
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Elanco
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Virbac
- HIPRA
- Veterquimica S.A.
- Tecnovax
- Phibro Animal Health Corporation
- Ridgeway Biologicals Ltd.
- Nisseiken Co., Ltd.
- Aquatic Animal Health Ltd
- Ictyogroup
- Benchmark Holdings plc
- Vaxxinova
- Alpha Biotech Ltd.
- Vallee S.A.
- Ringpu Biology
- Nippon Zenyaku Kogyo Co., Ltd.
- Chengdu Tech-bank Biological Products
- Weiyuan Gene Tech